Research Article
Determination of Cutoff Values for the Screening of Osteosarcopenia in Obese Postmenopausal Women
Table 5
Prevalence of OSO and its variations based on the new criteria and cutoff values (N = 141).
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
The sensitivity (Sn) is defined as the probability of a positive test in a diseased person (Sn = true positive ÷ true positive/false negative). The specificity (Sp) is defined as the likelihood of a negative test in a person without the disease (Sp = true negative ÷ true negative/false positive). Fourteen participants (n = 14, 10%) are normal weight with either sarcopenic or osteopenic/osteoporotic. OSO: osteosarcopenic obesity; OO: osteopenic obesity; SO: sarcopenia obesity; OB: obese-only; NR: healthy, normal weight; appSMMI: appendicular skeletal muscle mass index; SMMI: skeletal muscle mass index; FFMI: fat-free muscle mass index; BUA: broadband ultrasonic attenuation; BFP: body fat percent; HGS: handgrip strength. |